HomeSUVEN • NSE
add
Suven Life Sciences Ltd
Previous close
₹171.30
Day range
₹167.00 - ₹172.82
Year range
₹102.50 - ₹299.99
Market cap
38.26B INR
Avg Volume
173.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 9.19M | -64.27% |
Operating expense | 820.07M | 45.82% |
Net income | -773.10M | -55.73% |
Net profit margin | -8.41K | -335.90% |
Earnings per share | — | — |
EBITDA | -797.45M | -52.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.57B | 54.67% |
Total assets | 3.37B | 59.19% |
Total liabilities | 561.36M | 191.16% |
Total equity | 2.81B | — |
Shares outstanding | 222.15M | — |
Price to book | 13.53 | — |
Return on assets | — | — |
Return on capital | -103.62% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -773.10M | -55.73% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
138
